-

KARL STORZ IMAGE1 S Surgical Video System Earns Highest Cybersecurity Certification

The advanced endoscopic camera system is the first on the market to achieve certification through the UL Cybersecurity Assurance Program

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a leader in endoscopic imaging and operating room (OR) integration, is proud to announce that the IMAGE1 S® CONNECT II camera control unit has earned certification to UL 2900-2-1 through the UL Cybersecurity Assurance Program. UL 2900-2-1 is a national consensus standard published by the American National Standards Institute and recognized by the FDA as a path to fulfilling the agency’s cybersecurity testing recommendations for medical devices.

“Certification to the UL 2900 series of standards is the highest recognition of cybersecurity due diligence and helps demonstrate that a product or system is secure to modern standards,” said Christy Gaudet, VP, Sales and Marketing, OR1 & Surgical, KARL STORZ United States. “This certification is important for purchasers who want to mitigate risks by sourcing products validated by a trusted third party,” she said, adding, “IMAGE1 S is the first and only surgical camera system to achieve this certification.”

IMAGE1 S is a modular, scalable endoscopic imaging platform that allows users to add functionality as needed. The CONNECT II camera control unit is the heart of the system, enabling separate modules for working with rigid and flexible endoscopes in HD, 4K, 3D, and NIR/ICG imaging modes. It’s a vital component of the industry-leading OR integration solutions provided by KARL STORZ.

“Designed for modularity and backward and forward compatibility, IMAGE1 S gives users the confidence of knowing their surgical imaging equipment reflects the latest technical advances,” said Gaudet. “ULCAP certification gives them the further confidence of knowing their equipment has been rigorously tested against the latest cyberthreats—a major concern for healthcare network administrators.”

ULCAP certification is part of a longstanding effort at KARL STORZ to meet the most stringent cybersecurity requirements. Last year, KARL STORZ became the first provider of OR integration solutions to receive an Authorization to Operate (ATO) from the U.S. Department of Defense (DoD), Defense Health Agency (DHA). The company’s flagship OR integration products cleared extensive IT security and privacy controls and was deemed secure within certain deployment parameters for operation in military hospitals, clinics, and medical facilities.

“Cybersecurity isn’t an afterthought at KARL STORZ, it’s an integral part of our design process,” Gaudet said. “The risks of a cyberattack—particularly in terms of cost and disruptions to care—are simply too great to ignore.”

About KARL STORZ

For nearly 80 years, KARL STORZ has been recognized as a global leader in endoscopic technology and surgical imaging across virtually all surgical specialties. Its integrated OR solutions are intended to enhance collaboration to improve clinical efficiency and outcomes inside the hospital and other sites of care. KARL STORZ is a family-owned company based in Tuttlingen, Germany, that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. For more information, visit karlstorz.com.

Contacts

Media Contact:
Susan Mancia
Marketing Communications
KARL STORZ United States
(657) 385-5285

KARL STORZ


Release Versions

Contacts

Media Contact:
Susan Mancia
Marketing Communications
KARL STORZ United States
(657) 385-5285

Social Media Profiles
More News From KARL STORZ

ADDING MULTIMEDIA KARL STORZ Announces FDA Clearance for ENDOFLATOR + Insufflator and Smoke Evacuation System

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in minimally invasive surgical technology, is proud to announce it has received U.S. Food and Drug Administration (FDA) clearance for the ENDOFLATOR™ +. ENDOFLATOR + is the next-generation insufflator with integrated surgical smoke evacuation system designed to meet the evolving needs of modern operating rooms. Using carbon dioxide gas, an insufflator establishes and maintains a stable working cavity within the body during laparos...

KARL STORZ Unifies Canada, US, and Veterinary Organizations to Form North America Region Led by Sonal Matai

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a family-owned medical technology company headquartered in Tuttlingen, Germany, today announced the creation of a North America region that unifies its US, Canada, and Veterinary businesses under the leadership of Sonal Matai. Matai joined KARL STORZ in 2022 and was appointed to lead KARL STORZ United States in early 2024. As President of North America, Matai will now oversee key functions such as commercial operations, research and development,...

AventaMed, a KARL STORZ Company, Receives Expanded Indication for Solo+ Tympanostomy Tube Device (TTD)

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ United States is proud to announce that the US Food and Drug Administration (FDA) has cleared an expanded indication for the AventaMed Solo+™ Tympanostomy Tube Device (TTD), allowing its use in pediatric patients aged 6 months and older. This expanded clearance builds on the previous 510(k) clearance, which was indicated for patients 6 to 24 months old. The Solo+ device represents a significant advancement in pediatric ENT care. It is intended to...
Back to Newsroom